What is Emergent Biosolutions's free cash flow?

Emergent Biosolutions (EBS) reported free cash flow of -$36.2M in Q1 2026.

How has Emergent Biosolutions's free cash flow changed year-over-year?

Emergent Biosolutions's free cash flow decreased by 144.6% year-over-year, from -$14.8M to -$36.2M.

What does free cash flow mean?

Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.

Emergent Biosolutions EBS Free cash flow

Free cash flow at other companies

Thermo Fisher ScientificTMO

$816M+126%

Regeneron PharmaceuticalsREGN

$848.3M+4.0%

AMP

Amphastar PharmaceuticalsAMPH

$38.33M+57.2%

Amneal Pharmaceuticals, Inc.AMRX

-$34.92M-507%

CorMedixCRMD

$41.65M+111%

Collegium Pharmaceutical, Inc.COLL

$56.84M+4.1%

Other financials

Income statement

See full

Revenue$156.1M-29.7%

Gross profit$84.1M-37.1%

Operating income$10.5M-79.0%

Net income$6.8M-90.0%

EPS (diluted)$0.07-94.1%

Balance sheet

See full

Cash & equivalents$161.5M+5.7%

Total debt$584.6M-13.1%

Total equity$523.1M-5.4%

Total assets$1.3B-7.4%

Cash flow

See full

Operating cash flow-$33.8M-202%

CapEx$2.4M-33.3%

Valuation

See full

Market cap$411.74M+22.0%

Enterprise value$834.84M-2.6%

P/E3.6×—

P/S0.6×+0.3×

Profitability

See full

Gross margin54.2%+19.0pp

Operating margin15%+10.3pp

Net margin9.6%+5.8pp

FCF margin20.8%—

Returns & leverage

See full

Return on equity13.9%+8.1pp

Debt / equity1.1×-0.1×

Current ratio4.3×-2.0×

Where this comes from

Calculated from Emergent Biosolutions’s reported figures.

−$33.8Mnet cash from operating−$2.4Mcapital expenditures=-$36.2M

The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Emergent Biosolutions's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Emergent Biosolutions's free cash flow?: Emergent Biosolutions (EBS) reported free cash flow of -$36.2M in Q1 2026.
How has Emergent Biosolutions's free cash flow changed year-over-year?: Emergent Biosolutions's free cash flow decreased by 144.6% year-over-year, from -$14.8M to -$36.2M.
What does free cash flow mean?: Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.